Prévisions du marché des bioprocédés au Moyen-Orient et en Afrique jusqu\'en 2031 - Analyse régionale - par produit (instruments, consommables et accessoires), échelle d\'exploitation (opérations commerciales et opérations cliniques), processus (bioprocédés en aval et bioprocédés en amont), application (anticorps monoclonaux, vaccins, protéines recombinantes, thérapie cellulaire et génique, et autres) et utilisateur final (sociétés biopharmaceutiques, organisations de fabrication sous contrat, et autres)
L\'évolution vers la fabrication automatisée de thérapies cellulaires renforce le marché des bioprocédés au Moyen-Orient et en Afrique
Un nombre croissant de thérapies cellulaires ont fait passer la production de produits de thérapie cellulaire d\'un petit volume à un grand volume dans le monde entier. L\'augmentation des activités de recherche dans les thérapies cellulaires a entraîné une augmentation de la demande de solutions de fabrication avancées. Dans ce contexte, de nombreux acteurs proposent des produits pour répondre aux besoins des chercheurs universitaires et des grandes entreprises de biotechnologie. Par exemple, le Lonza Cocoon et le système CliniMACS Prodigy de Miltenyi sont conçus pour permettre l\'automatisation de la plupart des opérations unitaires séquentielles pour un processus CAR-T au sein d\'un seul système. En outre, l\'évolution de la thérapie cellulaire, du milieu universitaire et clinique à la production de masse et à la commercialisation, accroît la demande d\'automatisation dans la fabrication. En mai 2019, GE Healthcare a lancé l\'application Web Chronicle pour prendre en charge l\'ensemble du flux de travail de thérapie cellulaire. Le logiciel d\'automatisation Chronicle est une solution numérique conforme aux bonnes pratiques de fabrication, conçue pour optimiser le développement et la fabrication de processus complexes de thérapie cellulaire. Les entreprises se lancent également dans des développements stratégiques et technologiques pour l\'automatisation de la thérapie cellulaire. Par exemple, en juillet 2020, Thermo Fisher Scientific Inc. et Lyell Immunopharma se sont associés pour développer et fabriquer des processus permettant de concevoir des thérapies cellulaires efficaces pour les patients atteints de cancer. Dans le cadre de ce partenariat, les entreprises visent à améliorer la forme physique des lymphocytes T et à soutenir le développement d\'une plate-forme intégrée conforme aux BPF (système et logiciel) ainsi que des réactifs, des consommables et des instruments. En mars 2019, Lonza s\'est associé au centre médical Sheba d\'Israël pour fournir une fabrication automatisée et fermée de CAR-T à l\'aide de sa plate-forme de fabrication de thérapie cellulaire Cocoon au point de service. Les procédures automatisées peuvent réduire considérablement les coûts de production et améliorer la productivité du personnel et les taux de rétention. Outre ces facteurs, les processus automatisés limitent diverses sources possibles de contamination dans l\'unité de fabrication et améliorent finalement la cohérence des processus, ce qui se traduit par des produits de bonne qualité globale en réduisant les erreurs manuelles. Ainsi, l\'adoption croissante de l\'automatisation parmi les fabricants de thérapie cellulaire et les innovations de produits croissantes dans le domaine de la thérapie cellulaire sont susceptibles de stimuler le biotraitement ou la fabrication de thérapie cellulaire.
Aperçu du marché des bioprocédés au Moyen-Orient et en Afrique
Le marché des bioprocédés au Moyen-Orient et en Afrique est segmenté en Arabie saoudite, aux Émirats arabes unis, en Afrique du Sud et dans le reste du Moyen-Orient et de l\'Afrique. L\'Arabie saoudite détient la plus grande part du marché au Moyen-Orient et en Afrique. La prévalence croissante du cancer, l\'incidence croissante des troubles immunologiques, les initiatives favorables des gouvernements et une recrudescence des activités de recherche et développement sont quelques-uns des facteurs qui stimulent le marché dans cette région. Les ministères saoudiens signent des accords avec des sociétés de biotechnologie pour établir des installations de production dans le pays. Français Dans cette optique, les stratégies d\'expansion adoptées par les entreprises internationales pour renforcer leur présence au Moyen-Orient et en Afrique devraient profiter au marché du biotraitement dans les années à venir.
Chiffre d\'affaires et prévisions du marché du biotraitement au Moyen-Orient et en Afrique jusqu\'en 2031 (en millions de dollars américains)
Segmentation du marché du biotraitement au Moyen-Orient et en Afrique
Le marché du biotraitement au Moyen-Orient et en Afrique est classé en produit, échelle d\'opération, processus, application, utilisateur final et pays.
Sur la base du produit, le marché du biotraitement au Moyen-Orient et en Afrique est divisé en instruments et consommables et accessoires. Le segment des instruments détenait une part de marché plus importante en 2023. En outre, le segment des instruments est sous-segmenté en dispositifs de filtration, bioréacteurs, systèmes de chromatographie, centrifugeuses, dispositifs de séchage et autres. De plus, le sous-segment des bioréacteurs est classé en échelle pilote, échelle réelle et échelle de laboratoire. En outre, le sous-segment des systèmes de chromatographie est segmenté en chromatographie liquide, chromatographie en phase gazeuse et autres. Français De plus, le segment des consommables et accessoires est sous-segmenté en réactifs, milieux de culture cellulaire, résines de chromatographie et autres.
En termes d\'échelle d\'opération, le marché du biotraitement au Moyen-Orient et en Afrique est divisé en opérations commerciales et opérations cliniques. Le segment des opérations commerciales détenait une part de marché plus importante en 2023.
Par processus, le marché du biotraitement au Moyen-Orient et en Afrique est divisé en biotraitements en aval et en biotraitements en amont. Le segment des biotraitements en aval détenait une part de marché plus importante en 2023.
Sur la base de l\'application, le marché du biotraitement au Moyen-Orient et en Afrique est classé en anticorps monoclonaux, vaccins, protéines recombinantes, thérapie cellulaire et génique, et autres. Le segment des anticorps monoclonaux détenait la plus grande part de marché en 2023.
En termes d\'utilisateur final, le marché du biotraitement au Moyen-Orient et en Afrique est classé en sociétés biopharmaceutiques, organisation de fabrication sous contrat et autres. Français Le segment des sociétés biopharmaceutiques détenait la plus grande part de marché en 2023.
Par pays, le marché des bioprocédés au Moyen-Orient et en Afrique est segmenté en Arabie saoudite, en Afrique du Sud, aux Émirats arabes unis et dans le reste du Moyen-Orient et de l\'Afrique. L\'Arabie saoudite a dominé la part de marché des bioprocédés au Moyen-Orient et en Afrique en 2023.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Agilent Technologies Inc et Cytiva US LLC. sont quelques-unes des principales entreprises opérant sur le marché des bioprocédés au Moyen-Orient et en Afrique.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodologys
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioprocessing Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Biopharmaceutical Industry
4.2 Market Restraints
4.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
4.3 Market Opportunities
4.3.1 Proliferating Demand for Personalized Medicine
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact of Drivers and Restraints:
5. Bioprocessing Market - Middle East & Africa Analysis
5.1 Middle East & Africa Bioprocessing Market Overview
5.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
6. Middle East & Africa Bioprocessing Market Analysis - by Product
6.1 Overview
6.2 Instruments
6.2.1 Overview
6.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
6.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
6.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
6.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
6.3 Consumables & Accessories
6.3.1 Overview
6.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
7. Middle East & Africa Bioprocessing Market Analysis - by Scale of Operation
7.1 Overview
7.2 Commercial Operations
7.2.1 Overview
7.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Clinical Operations
7.3.1 Overview
7.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Bioprocessing Market Analysis - by Process
8.1 Overview
8.2 Downstream Bioprocess
8.2.1 Overview
8.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Upstream Bioprocess
8.3.1 Overview
8.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Middle East & Africa Bioprocessing Market Analysis - by Application
9.1 Overview
9.2 Monoclonal Antibodies
9.2.1 Overview
9.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Recombinant Protein
9.4.1 Overview
9.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Cell & Gene Therapy
9.5.1 Overview
9.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Middle East & Africa Bioprocessing Market Analysis - by End User
10.1 Overview
10.2 Biopharmaceutical Companies
10.2.1 Overview
10.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Contract Manufacturing Organization
10.3.1 Overview
10.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Middle East & Africa Bioprocessing Market - Country Analysis
11.1 Middle East & Africa
11.1.1 Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
11.1.1.1 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.1.1 Overview
11.1.1.2 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product
11.1.1.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments
11.1.1.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process
11.1.1.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application
11.1.1.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User
11.1.1.3 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.3.1 Overview
11.1.1.4 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.4.1 South Africa: Bioprocessing Market Breakdown, by Product
11.1.1.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments
11.1.1.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.4.2 South Africa: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.4.3 South Africa: Bioprocessing Market Breakdown, by Process
11.1.1.4.4 South Africa: Bioprocessing Market Breakdown, by Application
11.1.1.4.5 South Africa: Bioprocessing Market Breakdown, by End User
11.1.1.5 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product
11.1.1.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments
11.1.1.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process
11.1.1.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application
11.1.1.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User
11.1.1.7 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.7.1 Overview
11.1.1.8 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product
11.1.1.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments
11.1.1.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process
11.1.1.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application
11.1.1.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Bioprocessing Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Getinge AB
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Corning Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 3M Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eppendorf SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cytiva US LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Bioprocessing Market Segmentation
Table 2. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 6. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 7. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 8. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 9. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 10. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 11. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 12. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 13. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 14. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 15. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 16. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 17. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 18. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 19. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 20. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 21. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 22. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 23. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 24. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 25. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 26. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 27. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 29. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 30. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 31. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 32. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 33. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 34. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 35. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 36. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 37. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 38. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 39. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 40. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 41. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 42. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 43. Recent Organic Growth Strategies in the Bioprocessing Market
Table 44. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Middle East & Africa Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Middle East & Africa: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.